MDVIP, the national leader in personalized membership-based healthcare, today announced that the Private Equity business within Goldman Sachs Asset Management (“Goldman Sachs”) and Charlesbank Capital Partners (“Charlesbank”) have entered into a definitive agreement to acquire majority ownership of MDVIP from Leonard Green & Partners (“LGP”) and Summit Partners.

Founded in 2000, MDVIP leads the market in membership-based healthcare with a national network of over 1,100 primary care physicians serving 357,000 patients. In the MDVIP model, doctors have smaller practices compared to those in traditional, high-volume medicine. This allows them to spend more time with patients and provide attentive, individualized care with an emphasis on preventive health and wellness. MDVIP has achieved unrivaled patient satisfaction scores, which in addition to its annual membership renewals, consistently exceed 90 percent.

“The past 18 months have been a catalyst for Americans to become more engaged in their health, and many are recognizing the need for better prevention and coaching from a primary care doctor who really knows them,” said MDVIP Chairman and CEO Bret Jorgensen. “For 21 years, MDVIP has built and scaled its physician practice model to meet this consumer demand, and the market for our services will continue its momentum. This investment by Goldman Sachs and Charlesbank speaks to the strength and resiliency of our business model, and we are excited to partner with them as we embark on our next phase of growth.”

As part of its growth strategy, MDVIP is continuously expanding its portfolio of services to meet the needs of new customer segments. For example, the company is working with hospital systems to incorporate the MDVIP model into their primary care offering. To address the unique health concerns of women, the company has introduced a Women’s Health Program that pairs gynecological health with preventive primary care.  These are in addition to the company’s existing partnerships with employers to offer an executive health program as a benefit to employees.

“MDVIP has an impressive track record of delivering business growth to investors and proven healthcare outcomes that benefit patients, physicians and the healthcare system at large,” said Jo Natauri, Partner and Global Head of Private Healthcare Investing within Goldman Sachs Asset Management. “The company’s history and ability to adapt to a rapidly changing healthcare environment make it a strong addition to our investment portfolio, and we look forward to partnering with Charlesbank and the MDVIP management team.”

“MDVIP has a proven and innovative business model that represents the best in membership medicine,” said Brandon White, Managing Director at Charlesbank. “We are excited to back this talented management team as they build on their historical track record of outstanding services for physicians and members alike.” Added Josh Beer, also a Charlesbank Managing Director, “We look forward to working with Goldman Sachs to help MDVIP accelerate its growth and further solidify its position as the market leader in this consumer-driven healthcare landscape.”

Over time, the MDVIP primary care model has improved patient outcomes as demonstrated by clinical data published in ten peer-reviewed studies. The research shows that patients in MDVIP-affiliated practices have fewer heart attacks and strokes, better chronic care management of diseases like diabetes and high blood pressure, and more preventive screenings including regular colonoscopies, mammograms and bone density scans. Compared to patients in traditional practices, MDVIP members have also experienced reduced hospitalizations, lower hospital readmission rates and fewer visits to urgent care centers and emergency rooms, which have led to significant cost savings to the healthcare system.

Alyse Wagner, Partner at LGP, commented, “MDVIP continues to transform primary care for Americans across the country. It has proven to be a successful model for both doctors and patients, and we have great confidence in the future of its business.”

MDVIP Chairman and CEO Bret Jorgensen added, “This is a pivotal moment for U.S. healthcare companies, and we appreciate the support we received from Leonard Green & Partners and Summit Partners. We also thank our community of physicians, members and employees who every day are advancing MDVIP’s purpose of ‘making healthier lives happen.’”

The transaction is expected to close in Q4 following receipt of customary regulatory approvals. Financial terms were not disclosed.